Indian firms want compulsory licensing for price reasons to be fast-tracked
This article was originally published in Scrip
Executive Summary
Indian pharmaceutical companies have urged the government to consider "fast tracking" compulsory licensing (CL) applications made on the ground of non-affordable pricing.